Status:
RECRUITING
Association Between GalectiN-3 and POSt-operative AtrIal Fibrillation After Coronary Artery BypaSs Graft
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Post-operative Atrial Fibrillation
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to test the association between high levels of Galectin-3 and the occurrence of post-operative atrial fibrillation after isolated coronary artery bypass graftin...
Detailed Description
Prospective, observational, single-center cohort study including patients undergoing coronary artery bypass graft (CABG) surgery. Patients will be enrolled during preoperative evaluation. A periphera...
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing coronary artery bypass graft surgery
Exclusion Criteria:
- Inability to sign the free and informed consent form
- Renal dysfunction with estimated glomerular filtration rate less than 30ml / min / 1.73m² or dialysis therapy
- Moderate to severe left ventricular dysfunction (ejection fraction < 40%)
- Patients with previous atrial fibrillation
- Pregnancy
- Concomitant valve surgery
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06768528
Start Date
January 1 2023
End Date
December 1 2026
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto do Coração - Hospital das Clínicas - Faculdade de Medicina da Universidade de São Paulo
São Paulo, São Paulo, Brazil, 05403000